Table 4.
Secondary Outcome measures
| No-TXA (n=62) |
TXA (n=31) |
P | |
|---|---|---|---|
| Complications, % | |||
| DVT | 3.2% | 6.5% | 0.59 |
| PE (asymptomatic) | 3.2% | 0% | 0.55 |
| PE (symptomatic) | 3.2% | 3.2% | 1.00 |
| SIRS | 47% | 77% | 0.007 |
| AKI | 19% | 45% | 0.01 |
| Infections | 24% | 32% | 0.46 |
| ARDS | 16% | 19% | 0.77 |
| Sepsis | 16% | 35% | 0.04 |
| Multiple organ failure | 6.4% | 19% | 0.01 |
| Stroke | 3.2% | 3.2% | 1.00 |
| Hospital length of stay, median [IQR] | 4 [1–18] | 7 [1 – 22] | 0.30 |
| ICU free days, median [IQR] | 0 [0–5] | 0 [0 – 3] | 0.22 |
| Ventilator days, median [IQR] | 0 [0–7] | 0 [0 – 7] | 0.52 |
IQR=Interquartile Range, ICU=Intensive Care Unit, DVT=Deep Venous Thrombosis, PE=Pulmonary embolism, SIRS=Systemic Inflammatory Response Syndrome, AKI=Acute Kidney Injury, ARDS=Acute Respiratory Distress Syndrome